Navigation Links
DVT Awareness Survey Findings: Heart and Respiratory Patients

WASHINGTON, March 06, 2007 /PRNewswire/ -- Up to two million Americans are affected each year by DVT, with up to 600,000 hospitalized. Its primary complication, pulmonary embolism (PE), claims up to 300,000 lives annually -- more than breast cancer and AIDS combined. People who suffer from cardiovascular disease may be at increased risk for DVT, because these factors also heighten the likelihood of blood clots and pooling. Respiratory tract infection may increase risk of blood clots and is associated with inflammation, which may affect the proper functioning of arteries and veins.

The Coalition to Prevent Deep-Vein Thrombosis (DVT) recently sponsored an online survey of a nationally representative sample of consumers and physicians. The survey, which was conducted by Penn, Schoen & Berland Associates, assessed what Americans know about DVT.

The survey results point to an ongoing need for patients and physicians alike to know more about this leading cause of death and how they can reduce the risk of DVT. Following are the results specific to respiratory disease.

    Heart/respiratory patients recognize the significance of heart disease as

    a risk factor for DVT but incorrectly view pulmonary/respiratory disease

    as a much less significant threat.

       * 60% of heart/respiratory patients rate cardiac issues (e.g., heart

         disease, heart attack, arteriosclerosis or CHF) as very significant

         risk factors for DVT.

       * Only 35% see pulmonary/respiratory disease (e.g., asthma, COPD or

         emphysema) as a very significant risk factor.


    Even though they are at greater risk for DVT, heart/respiratory patients

    know only as much about it as the general population.

       * 52% of heart/respiratory patients have some knowledge about DVT -- on

         par with the general population (51%).

       * 40% of heart/respiratory patients have heard or read about DVT

         recently, the same percent
age as in the general population.


    Heart/respiratory patients who know something about DVT are no more likely

    than the general population to recognize key facts about the condition.

       * 17% of heart/respiratory patients correctly identify DVT as a blood

         clot, the same percentage as in the general population.

       * 17% recognize that DVT is a dangerous condition, one that can cause

         stroke or heart attack, or one that can be fatal.


    Despite their greater risk, heart/respiratory patients are no more likely

    than the general population to have discussed DVT with their physicians.

       * 10% of heart/respiratory patients report that their primary care

         physician has discussed DVT with them, compared with 12% of the

         general population.

       * 55% of heart/respiratory patients say that they are likely to ask

         their physicians for DVT information, vs. 50% of the general

         population.

The Coalition to Prevent Deep-Vein Thrombosis is funded by sanofi-aventis U.S. LLC

US.ENO.07.01.122

CONTACT: Shannon McIntyre, +1-212-614-4351

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Related medicine technology :

1. Survey Reveals Significant Public Lack of Diabetes Awareness
2. DVT Awareness Survey Findings for Respondents in High-Risk Groups: Obese Individuals
3. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
4. Women Well-Informed About Breast Cancer, Yet Lacking Knowledge About Current Treatments, New Survey Finds
5. Waismann Method Survey Reveals Dependency Risk for People Using Suboxone
6. Hypertension Education Foundation Survey Results Announced At American Society For Hypertension Annual Meeting Suggests Improved Control Of High Blood Pressure, But Misconceptions Still Exist
7. Survey: Migraine Patients Taking Potentially Addictive Barbiturate or Opioid Medications Not Approved by FDA as Migraine Treatments
8. New Survey Finds Troubling Data on American Asthma Sufferers
9. Waismann Method Survey Reveals 65 Percent of Women Seeking Opiate Dependency Treatment Are Mothers
10. Medical Journal Publishes First Large-Scale Survey Revealing Experiences of IPF Patients
11. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... June 26, 2016 One of Australia,s ... the formation of a new biotechnology company, Noxopharm Limited [ABN 50 ... an IPO and to list on the ASX. Noxopharm ... ready to enter a Phase 1 clinical study later this year. ... address one of the biggest problems facing cancer patients - the ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway ... call for a minimum wage raise to $12 an hour by 2020 and then adjusting ... restore the lost value of the minimum wage, assure the wage floor does not erode ...
(Date:6/24/2016)... Georgia (PRWEB) , ... June 24, 2016 , ... ... awards today at the Clinical Decision Making in Emergency Medicine conference in Ponte ... have authored journal articles published in Emergency Medicine Practice and Pediatric ...
Breaking Medicine News(10 mins):